Метаболизм железа, ферроптоз, рак
https://doi.org/10.17650/1726-9784-2017-16-3-14-20
Аннотация
В 2012 г. была описана новая, железозависимая форма клеточной гибели - ферроптоз, отличающаяся по морфологическим, биохимическим и генетическим особенностям от апоптоза, аутофагии и программируемого некроза. В обзоре обсуждаются вопросы метаболизма железа в норме и при злокачественных новообразованиях, молекулярные характеристики ферроптоза и возможности терапии онкологических больных в свете новых данных.
Список литературы
1. Kleingardner J.G., Bren K.L. Biological significance and applications of heme proteins and peptides. Acc Chem Res 2015;48(7):1845-52. DOI: 10.1021/acs. accounts.5b00106. PMID: 26083801.
2. Zhang D.L., Ghosh M.C., Rouault T.A. The physiological functions of iron regulatory proteins in iron homeostasis - an update. Frontiers in pharmacology 2014;5:124-129. PMID: 24982634.
3. Munoz M., Villar I., Garcia-Erce J.A. An update on iron physiology. World journal of Gastroenterology 2009;15:4617-4626. PMID: 19787824.
4. Soares M.P., Weiss G. The Iron age of host-microbe interactions. EMBO Rep 2015;16(11):1482-500. DOI: 10.15252/embr. 201540558. PMID: 26474900.
5. Li K., Reichmann H. Role of iron in neurodegenerative diseases. J Neural Transm (Vienna) 2016;123(4):389-99. DOI: 10.1007/s00702-016-1508-7. PMID: 26794939.
6. Yevenes A. The ferritin superfamily. Subcell Biochem 2017;83:75-102. DOI: 10.1007/978-3-319-46503-6-3. PMID: 28271473.
7. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011;434:365-381. PMID: 21348856.
8. Dixon S.J., Stockwell B.R. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;49:1060-1072. PMID: 22632970.
9. Xie Y., Hou W., Song X. et al. Ferroptosis: process and function. Cell Death Differ 2016;23:369-379. DOI: 10.1038/cdd.2015.158. PMID: 26794443.
10. Wallace D.F. The Regulation of Iron Absorption and Homeostasis. Clin Biochem Rev 2016;37(2):51-62. PMID: 28303071.
11. Reichert C.O., da Cunha J., Levy D. et al. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism. Acta Haematol 2017;137(4):220-236. DOI: 10.1159/000471838. PMID: 28514781.
12. Ludwig H., Evstatiev R., Kornek G. et al. Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr 2015;127(23-24):907-19. DOI: 10.1007/ s00508-015-0842-3. PMID: 26373748.
13. Kabat G.C., Rohan T.E. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control 2007;18(10):1047-53. PMID: 17823849.
14. Gozzelino R., Arosio P. Iron Homeostasis in Health and Disease. Int J Mol Sci 2016;17(1):E130 - E138. DOI: 10.3390/ijms17010130. PMID: 26805813.
15. Drakesmith H., Nemeth E., Ganz T. Ironing out Ferroportin. Cell metabolism 2015;22(5):777-87. DOI: 10.1016/j.cmet.2015.09.006. PMID: 26437604.
16. Kew M.C. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer 2014;3(1):31-40. DOI: 10.1159/000343856. PMID: 24804175.
17. Dolma S., Lessnick S.L., Hahn W.C. et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 2003;3:285-96. PMID: 12676586.
18. Yang W.S., Stockwell B.R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 2008;15:234-45. PMID: 18355723.
19. Bedford M.R., Ford S.J., Horniblow R.D. et al. Iron chelation in the treatment of cancer: a new role for deferasirox? J Clin Pharmacol 2013;53(9):885-91. DOI: 10.1002/jcph.113. PMID: 23740857.
20. Dixon S.J. Ferroptosis: bug or feature? Immunol Rev 2017;277(1):150-7. DOI: 10.1111/imr.12533. PMID: PMID:28462529.
21. Meister A. Glutathione metabolism. Methods Enzymol 1995;251:3-7. PMID: 7651209.
22. Brigelius-Flohe R., Maiorino M. Glutathione peroxidases. Biochim Biophys Acta 2013;1830:3289-303. PMID: 23201771.
23. Kidane T.Z., Sauble E., Linder M.C. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 2006;291:C445-55. DOI: 10.1152/ajpcell.00505.2005.
24. Terman A., Kurz T. Lysosomal iron, iron chelation, and cell death. Antioxid Redox Signal 2013;18(8):888-98. DOI: 10.1089/ars.2012.4885. PMID: 22909065.
25. Yagoda N., von Rechenberg M., Zaganjor E. et al. RAS-RAFMEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007;447:864-8. DOI: 10.1038/nature05859. PMID: 17568748.
26. Cao J.Y., Dixon S.J. Mechanisms of ferroptosis. Cell Mol Life Sci 2016;73:2195-209. DOI: 10.1007/s00018-016-2194. PMID: 27048822.
27. Fonseca-Nunes A., Jakszyn P., Agudo A. Iron and cancer risk - a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev 2014;23:12-31. PMID: 24243555.
28. Turner N.D., Lloyd S.K. Association between red meat consumption and colon cancer: A systematic review of experimental results. Exp Biol Med(Maywood) 2017;42(8):813-39. DOI: 10.1177/1535370217693117. PMID: 28205448.
29. Corce V., Gouin S.G., Renaud S. et al. Recent advances in cancer treatment by iron chelators. Bioorg Med Chem Lett 2016;26(2):251-6. DOI: 10.1016/j.bmcl.2015.11.094. PMID: 26684852.
30. Zacharski L.R., Chow B.K., Howes P.S. et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008;100(14):996-1002. DOI: 10.1093/jnci/djn209. PMID: 18612130.
31. Durigova A., Jacot W., Pouderoux S. et al. Iron metabolism in breast cancer: knowledge and future. Ann Biol Clin (Paris) 2012;70(4):387-96. PMID: 22796610.
32. Xue D., Zhou C.X., Shi Y.B. et al. Decreased expression of ferroportin in prostate cancer. Oncol Lett 2015;10(2):913-6. PMID: 26622594.
33. Wang Q., Zhou J., Zhong D. et al. Ferroportin in the progression and prognosis of hepatocellular carcinoma. Eur J Med Res 2013. DOI: 10.1186/2047-783X-18-59. PMID: 24360312.
34. Nicolae C.D., Coman O.A., Ene C. et al. Hepcidin in neoplastic disease. J Med Life 2013;15;6(3):355-60. PMID: 24146699.
35. Yu H., Guo P., Xie X. et al. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med 2017;21(4):648-57. DOI: 10.1111/jcmm.13008. PMID: 27860262.
36. Ivanov S.D., Semenov A. L., Mikhelson V.M. et al. Effects of iron ion additional introduction in radiation therapy of tumor-bearing animals. Radiats Biol Radioecol 2013;53(3): 296-303. PMID: 24450211.
37. Daniels T.R., Delgado T., Helguera G. et al. The transferrin receptor: targeted delivery of therapeutic agents into cancer cells. Clinical immunology (Orlando, Fla) 2006;121:159-76. PMID: 16920030.
38. Daniels T. R., Delgado T., Rodriguez J.A. et al. The transferrin receptor: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006; 121(2):144-58. PMID: 16904380.
39. Kiessling M.K., Klemke C.D., Kaminski M.M. et al. Inhibition of constitutively activated NF-kB induces ROS- and iron dependent cell death in cutaneous T cell lymphoma. Cancer Res 2009;69(6):2365-74. DOI: 10.1158/0008-5472. PMID: 19258503.
40. Lachaier E., Louandre C., Godin C. et al. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res 2014;34:6417-22. FMID: 25368241.
41. Ohara T., Noma K., Urano S. et al. A novel synergistic effect of iron depletion on antiangiogenic cancer therapy. Int J Cancer 2013;132(11): 2705-13. DOI: 10.1002/ijc.27943. PMID: 23161652.
42. Kitamura H., Koike S., Nakazawa K. et al. A reversal in the vascularity of metastatic liver tumors from colorectal cancer after the cessation of chemotherapy plus bevacizumab: contrast-enhanced ultrasonography and histological examination. J Surg Oncol 2013;107(2):155-9. DOI: 10.1002/jso.23244. PMID: 22903532.
43. Schonberg D.L., Miller T.E., Wu Q. et al. Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. Cancer Cell 2015;28:441-55. PMID: 26461092.
44. Green D.R., Victor B. The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol 2012;22:555-6. DOI: 10.1016/j.tcb.2012.08.008. PMID: 22995729.
Рецензия
Для цитирования:
Вартанян А.А. Метаболизм железа, ферроптоз, рак. Российский биотерапевтический журнал. 2017;16(3):14-20. https://doi.org/10.17650/1726-9784-2017-16-3-14-20
For citation:
Vartanian A.A. Iron metabolism, ferroptosis and cancer. Russian Journal of Biotherapy. 2017;16(3):14-20. (In Russ.) https://doi.org/10.17650/1726-9784-2017-16-3-14-20
Просмотров: 590
Послать статью по эл. почте 
